These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 26635203)
1. MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours. Perlman EJ; Gadd S; Arold ST; Radhakrishnan A; Gerhard DS; Jennings L; Huff V; Guidry Auvil JM; Davidsen TM; Dome JS; Meerzaman D; Hsu CH; Nguyen C; Anderson J; Ma Y; Mungall AJ; Moore RA; Marra MA; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Gastier-Foster JM; Ross N; Smith MA Nat Commun; 2015 Dec; 6():10013. PubMed ID: 26635203 [TBL] [Abstract][Full Text] [Related]
2. The Intrinsically Disordered Proteins MLLT3 (AF9) and MLLT1 (ENL) - Multimodal Transcriptional Switches With Roles in Normal Hematopoiesis, MLL Fusion Leukemia, and Kidney Cancer. Kabra A; Bushweller J J Mol Biol; 2022 Jan; 434(1):167117. PubMed ID: 34174329 [TBL] [Abstract][Full Text] [Related]
3. Structure and Inhibitor Binding Characterization of Oncogenic MLLT1 Mutants. Ni X; Londregan AT; Owen DR; Knapp S; Chaikuad A ACS Chem Biol; 2021 Apr; 16(4):571-578. PubMed ID: 33749253 [TBL] [Abstract][Full Text] [Related]
4. Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies. Fukuzawa R; Heathcott RW; More HE; Reeve AE J Clin Pathol; 2007 Sep; 60(9):1013-6. PubMed ID: 17172473 [TBL] [Abstract][Full Text] [Related]
5. Discovery of an MLLT1/3 YEATS Domain Chemical Probe. Moustakim M; Christott T; Monteiro OP; Bennett J; Giroud C; Ward J; Rogers CM; Smith P; Panagakou I; Díaz-Sáez L; Felce SL; Gamble V; Gileadi C; Halidi N; Heidenreich D; Chaikuad A; Knapp S; Huber KVM; Farnie G; Heer J; Manevski N; Poda G; Al-Awar R; Dixon DJ; Brennan PE; Fedorov O Angew Chem Int Ed Engl; 2018 Dec; 57(50):16302-16307. PubMed ID: 30288907 [TBL] [Abstract][Full Text] [Related]
6. The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours. Ramani P; Cowell JK J Pathol; 1996 Jun; 179(2):162-8. PubMed ID: 8758208 [TBL] [Abstract][Full Text] [Related]
7. Multiple mechanisms of MYCN dysregulation in Wilms tumour. Williams RD; Chagtai T; Alcaide-German M; Apps J; Wegert J; Popov S; Vujanic G; van Tinteren H; van den Heuvel-Eibrink MM; Kool M; de Kraker J; Gisselsson D; Graf N; Gessler M; Pritchard-Jones K Oncotarget; 2015 Mar; 6(9):7232-43. PubMed ID: 25749049 [TBL] [Abstract][Full Text] [Related]
8. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes. Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682 [TBL] [Abstract][Full Text] [Related]
9. Expression and localization of HGF and met in Wilms' tumours. Alami J; Williams BR; Yeger H J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645 [TBL] [Abstract][Full Text] [Related]
10. Discovery of PFI-6, a small-molecule chemical probe for the YEATS domain of MLLT1 and MLLT3. Raux B; Buchan KA; Bennett J; Christott T; Dowling MS; Farnie G; Fedorov O; Gamble V; Gileadi C; Giroud C; Huber KVM; Korczynska M; Limberakis C; Narayanan A; Owen DR; Sáez LD; Stock IA; Londregan AT Bioorg Med Chem Lett; 2024 Jan; 98():129546. PubMed ID: 37944866 [TBL] [Abstract][Full Text] [Related]
11. Nuclear accumulation of beta-catenin protein in Wilms' tumours. Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228 [TBL] [Abstract][Full Text] [Related]
13. CITED1 expression in Wilms' tumor and embryonic kidney. Lovvorn HN; Westrup J; Opperman S; Boyle S; Shi G; Anderson J; Perlman EJ; Perantoni AO; Wills M; de Caestecker M Neoplasia; 2007 Jul; 9(7):589-600. PubMed ID: 17710162 [TBL] [Abstract][Full Text] [Related]
14. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis. Pritchard-Jones K; Fleming S Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569 [TBL] [Abstract][Full Text] [Related]
15. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia. Cheah PL; Looi LM; Chan LL Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120 [TBL] [Abstract][Full Text] [Related]
17. ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemia. Zhou J; Ng Y; Chng WJ Cell Mol Life Sci; 2018 Nov; 75(21):3931-3941. PubMed ID: 30066088 [TBL] [Abstract][Full Text] [Related]
18. Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq. Phelps HM; Al-Jadiry MF; Corbitt NM; Pierce JM; Li B; Wei Q; Flores RR; Correa H; Uccini S; Frangoul H; Alsaadawi AR; Al-Badri SAF; Al-Darraji AF; Al-Saeed RM; Al-Hadad SA; Lovvorn Iii HN World J Pediatr; 2018 Dec; 14(6):585-593. PubMed ID: 30155617 [TBL] [Abstract][Full Text] [Related]
19. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development. Charles AK; Brown KW; Berry PJ Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048 [TBL] [Abstract][Full Text] [Related]
20. Identification of a novel isoform of the leukemia-associated MLLT1 (ENL/LTG19) protein. Wallingford MC; Filkins R; Adams D; Walentuk M; Salicioni AM; Visconti PE; Mager J Gene Expr Patterns; 2015 Jan; 17(1):11-5. PubMed ID: 25481096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]